erythropoietin
Sympathetic innervation into the kidneys can lead to several functions such as vasoconstriction of renal blood vessels, stimulation of renin release from the juxtaglomerular cells, and reduction in urine production by decreasing blood flow to the kidneys. These responses help regulate blood pressure and maintain overall body fluid balance.
The type of hypotension characterized by a decreasing efficiency of the sympathetic nervous system's vasoconstrictor functioning is known as neurogenic hypotension. This condition occurs when there is a disruption in the autonomic nervous system's ability to regulate blood vessel tone, often due to factors such as spinal cord injury, severe emotional stress, or certain medical conditions. As a result, blood vessels may remain dilated, leading to reduced systemic vascular resistance and lower blood pressure.
G-CSF (granulocyte colony-stimulating factor) is helpful in stimulating the bone marrow to produce more white blood cells, specifically neutrophils. It is commonly used to prevent or treat low white blood cell counts in patients receiving chemotherapy or undergoing bone marrow transplantation.
Blood accumulates in the pleural cavity when hemothorax is diagnosed. This can result from trauma, surgery, or certain medical conditions where blood leaks from blood vessels into the pleural space, causing difficulty in breathing and chest pain. Treatment may involve drainage of the blood to relieve symptoms and prevent complications.
Are you sure you mean white blood cells and not red blood cells? Erythropoietin (Darbepoetin alfa or Aranesp) stimulates erythroblast (red blood cell) precursors in the bone marrow to proliferate, eventually increasing the red blood cell count. Source: I am a medical student.
Myelosuppression
Strokes.
Yes, chemotherapy treatment can lead to the development of anemia. This is because chemotherapy can affect the production of red blood cells in the bone marrow, leading to a decrease in the number of red blood cells in the body, which can result in anemia.
The correct answer is faintness, dizziness.
Chemotherapy is different than localized treatments of cancer because it is cytotoxic, or kills some of the blood cells in the body. In chemotherapy treatment, patients are given medication that travels throughout the body and destroys any cancer cells that are present.
The correct answer is faintness, dizziness.
No, chemotherapy does not change blood type. Blood type is determined by genetic factors and remains the same throughout a person's life. Chemotherapy may affect the levels of blood cells in the body, but not the blood type itself.
Chemotherapy results in anemia due to the biological wasteland the chemotherapy causes. After chemotherapy, all things bad and good will die, and the body will have to replenish those things. Anemia is almost always temporary after such a process.
Neulasta is used after chemotherapy to increase the production of white blood cells. Chemotherapy decreases white blood cell production, and therefore increases the risk of infection.
Chemotherapy given by intramuscular injection is absorbed into the blood more slowly than IV chemotherapy. Because of this, the effects of IM chemotherapy may last longer than chemotherapy given intravenously.
Some types of chemotherapy lower your red blood cell and/or white blood cell counts. It is important to monitor the white blood cell count to know if a patient is at risk of developing infections. Low red blood cell counts, also known as anemia, also needs to be monitored and can be treated to help prevent fatigue. Both counts, and also platelets, the third of the blood cell lines, are monitored with a CBC (complete blood count) on the day of chemotherapy and sometimes weekly during treatment.
If you are a hemophiliac (a genetic disorder) your blood will not clot. Also certain medicines such as Warfarin or Heparin will act as anticoagulants and prevent blood from clotting. People undergoing chemotherapy for cancer also have problems with blood not clotting due to a reduction in the number of platelets present in the blood.